Antibody Responses Against Proteins of Different Molecular Weight Following Inoculation of Formalin Inactivated Acinetobacter baumannii in Mice
Open Access
- 31 March 2025
- journal article
- Published by Science Publishing Group in International Journal of Immunology
- Vol. 13 (1) , 1-8
Abstract
Acinetobacter baumannii is one of the most significant threats to global public health with a seemingly limitless capacity for antimicrobial resistance. Developing preventive vaccines to combat these pathogens can provide long-term protective immunity. This study was conducted to evaluate the specific protein against which the protective antibody is produced in serum and splenic cell culture supernatant after vaccination in mice. The vaccine used was a formaldehyde-inactivated whole-cell vaccine against multidrug resistant (MDR) A. baumannii. MDR A. baumannii , isolated from different samples, used in formaldehyde-inactivated vaccine and inoculated intradermally in experimental mice. Serum was collected from tail blood on days 13, 27 and 41 following 1st immunization. Two weeks after 3 rd immunization, mice were challenged with live A. baumannii intraperitoneally and observed for 14 days. Sera from tail blood and mouse spleens were collected. MDR A. baumannii antigen was sonicated and Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis was performed. Protective antibodies that bind with antigens in serum and culture supernatant were evaluated by ELISA. Survival rates were observed to be 100% at 14 days post-challenge among the immunized mice. Serum from pre- and post-challenge immunizations showed considerably greater optical density (OD) values of IgG than control mice. Although antibodies are developed against several antigens of different molecular weights, the protein fraction of 30-40 kDa showed a higher OD value. Formalin-inactivated intradermal immunization with MDR A. baumannii produced protective antibodies in mice against proteins of specific molecular weights. Proteins of 30-40 kDa molecular weights could be used as vaccine candidates to prevent A. baumannii infection.Keywords
This publication has 16 references indexed in Scilit:
- Insights into mucoid Acinetobacter baumannii: A review of microbiological characteristics, virulence, and pathogenic mechanisms in a threatening nosocomial pathogenMicrobiological Research, 2022
- Vaccine development to control the rising scourge of antibiotic-resistant Acinetobacter baumannii: a systematic review3 Biotech, 2022
- Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infectionsMicrobial Pathogenesis, 2020
- A new strain of Acinetobacter baumannii and characterization of its ghost as a candidate vaccineJournal of Infection and Public Health, 2019
- Protective effects of oral immunization with formalin-inactivated whole-cell Citrobacter rodentium on Citrobacter rodentium infection in miceJournal of Microbiological Methods, 2019
- Hydrogen peroxide-inactivated bacteria induces potent humoral and cellular immune responses and releases nucleic acidsInternational Immunopharmacology, 2019
- Trypan Blue Exclusion Test of Cell ViabilityCurrent Protocols in Immunology, 2015
- Immunoproteomics: The Key to Discovery of New Vaccine Antigens Against Bacterial Respiratory InfectionsCurrent Protein & Peptide Science, 2012
- Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccineVaccine, 2010
- Global Challenge of Multidrug-ResistantAcinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2007